生物制药公司Revolution Medicines, Inc. (RVMD)宣布已完成同步扩大规模的公开发行,总募资金额约达22亿美元。此次发行包含承销商全额行使超额配售权购入的额外股份。
生物制药公司Revolution Medicines, Inc. (RVMD)宣布已完成同步扩大规模的公开发行,总募资金额约达22亿美元。此次发行包含承销商全额行使超额配售权购入的额外股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.